Stanford University 3rd Annual Spinal Muscular Atrophy Continuing Medical Education Conference on Clinical Decision-Making in the Midst of an Unfolding Phenotype (Recorded Sessions)


Stanford University 3rd Annual Spinal Muscular Atrophy Continuing Medical Education Conference on Clinical Decision-Making in the Midst of an Unfolding Phenotype (Recorded Sessions) Banner



Date & Location
Monday, March 14, 2022, 12:00 AM - Thursday, March 13, 2025, 11:59 PM, On Demand

Overview

Internet Enduring Material Sponsored by Stanford University School of Medicine. Presented by the Division of Neuromuscular Medicine at Stanford University School of Medicine. 

Continuing medical education and training is building momentum among the healthcare community treating and managing individuals with SMA.  In this era of disease-modifying treatments, evolving SMA phenotypes are unfolding and clinical decision-making is requiring greater attention for the most optimal outcomes.  Multidisciplinary medical and rehabilitative management recommendations are sought after while weighing the treatment options, long term outcomes, and ethical considerations to effectively treat and manage patients with SMA.  We intend to continue to enhance the knowledge and understanding of healthcare providers including physicians, specialists, physical, occupational, and speech language pathologist and nurses, outside specialized centers, in the clinical decision-making and medical and rehabilitative management of individuals with SMA. 

This recorded series is provided to (1) integrate new 2021 treatment advances into clinical decision-making; and (2) use new SMA standards as a model for public health, primary and multi-disciplinary care of all children and adults with neuromuscular disease. 

This recorded educational lecture series provides an overview of SMA therapeutic treatment updates and clinical decision-making for optimal outcomes, the impact of newborn screening, as well as primary and multi-disciplinary care for children and adults living with SMA.  The didactic videos provide an in depth review of rehabilitation evidence, with a specific focus on multidisciplinary clinical case discussions.  The recordings include clinical decision-making for the evolving phenotypes as well as a shared recorded session to support multi-disciplinary providers to medically manage and develop rehabilitation programs and episodes of care including evaluations, goals, interventions and strategies to exercise.

At the end of this course, participants will have an understanding of the current advances in therapeutic treatments, clinical, and rehabilitative management in SMA. Learners will understand opportunities available to enhance clinical care, determine the most appropriate treatment, medical and rehabilitative interventions, and contemplate the ethical debates to treatment and management.


Registration

Release Date: March 14, 2022
Expiration Date: March 13, 2025
Estimated Time to Complete: 7.25 hours
Registration Fee: FREE 
*Originally recorded on 12/2/2021 - 12/4/2021.


Credits
AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Participation Credit (7.25 hours)

Target Audience
Specialties - Internal Medicine, Neurology , Pediatrics, Physical Therapy, Speech Language Pathology
Professions - Advance Practice Nurse (APN), Fellow/Resident, Non-Physician, Nurse, Physical Therapist, Physician, Physician Associate, Psychologist, Registered Nurse (RN), Social Worker, Student

Objectives
At the conclusion of this activity, learners should be able to:  

  1. Summarize the advancements and barriers of providing therapeutic treatments for individuals with SMA.
  2. Recognize and discuss the impact of newborn screening, primary, and multi-disciplinary clinical care for children and adults with SMA in this era of evolving phenotypes and therapeutics.
  3. Determine and select suitable rehabilitation programs based on evidence and clinical decision-making for optimal outcomes including standards of care recommendations.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 7.25 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Additional Information

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

Reference/Bibliography
Click HERE to view a full list of references and resources.  

For activity related questions, please contact
     Name: Brandon Armstrong, MHA
     Title: CME Compliance Coordinator
     Ph: (650) 721-2392 
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]